Skip to main content
Top
Published in: CEN Case Reports 4/2019

01-11-2019 | Wernicke's Encephalopathy | Case Report

Uremic encephalopathy in patients undergoing assisted peritoneal dialysis: a case series and literature review

Authors: Akane Yanai, Kiyotaka Uchiyama, Yoshitaka Ishibashi

Published in: CEN Case Reports | Issue 4/2019

Login to get access

Abstract

We sometimes hesitate to switch renal replacement therapy from peritoneal dialysis (PD) particularly in elderly patients due to their physical tolerance levels and lifestyles. Here, we describe the cases of three patients treated with PD alone despite an anuric status who subsequently developed uremic encephalopathy, which was successfully treated with hemodialysis (HD). The first patient was a 75-year-old woman who developed uremic encephalopathy with an anuric status and inadequate PD after 7 months of treatment. HD immediately improved her condition; encephalopathy did not recur with combined therapy of PD and HD. The second patient was a 69-year-old woman who developed anuria and was treated with combined therapy. Her arteriovenous fistula was obstructed; therefore, she was treated with PD alone. Total weekly Kt/V was sufficiently high at 1.95; however, she developed uremic encephalopathy the following month, which was successfully treated with HD. The third patient was an 84-year-old woman who developed anuria, but was treated with PD alone with adequate total weekly Kt/V of 2.2. PD could not be performed for 2 days because of myocardial infarction intervention; subsequently, she developed uremic encephalopathy, which was successfully treated with HD. These cases are the first of their kinds, wherein patients undergoing PD, developed uremic encephalopathy without any obvious triggers, including drugs, and illustrate the necessity of initiating combined therapy for such patients considering the risk of developing severe uremia leading to uremic encephalopathy, in spite of it being less preferable for elderly patients due to their physical conditions and lifestyles.
Literature
1.
go back to reference Suzuki H, Hoshi H, Inoue T, Kikuta T, Takane H, Takenaka T, Watanabe Y, Okada H, Kimura Y. Long-term survival benefits of combined hemodialysis and peritoneal dialysis. Adv Perit Dial. 2014;30:31–5.PubMed Suzuki H, Hoshi H, Inoue T, Kikuta T, Takane H, Takenaka T, Watanabe Y, Okada H, Kimura Y. Long-term survival benefits of combined hemodialysis and peritoneal dialysis. Adv Perit Dial. 2014;30:31–5.PubMed
2.
go back to reference Kumar VA, Sidell MA, Jones JP, Vonesh EF. Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system. Kidney Int. 2014;86:1016–22.CrossRef Kumar VA, Sidell MA, Jones JP, Vonesh EF. Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system. Kidney Int. 2014;86:1016–22.CrossRef
3.
go back to reference Denker BM, Chertow GM, Owen WF Jr. Hemodialysis. In: Brenner BM, editor. The kidney. 6th ed. Philadelphia: Saunders; 2000. p. 2373. Denker BM, Chertow GM, Owen WF Jr. Hemodialysis. In: Brenner BM, editor. The kidney. 6th ed. Philadelphia: Saunders; 2000. p. 2373.
4.
go back to reference Lorber D. Nonketotic hypertonicity in diabetes mellitus. Med Clin North Am. 1995;79:39–52.CrossRef Lorber D. Nonketotic hypertonicity in diabetes mellitus. Med Clin North Am. 1995;79:39–52.CrossRef
5.
go back to reference Wang AY, Woo J, Wang M, Sea MM, Ip R, Li PK, Lui SF, Sanderson JE. Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol. 2001;12:1927–36.PubMed Wang AY, Woo J, Wang M, Sea MM, Ip R, Li PK, Lui SF, Sanderson JE. Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol. 2001;12:1927–36.PubMed
6.
go back to reference e Silva AD, Todorov JC, Lobo OD. Effect of experimentally induced chronic renal failure upon the behavior of rats. Nephron. 1979;24:78–80.CrossRef e Silva AD, Todorov JC, Lobo OD. Effect of experimentally induced chronic renal failure upon the behavior of rats. Nephron. 1979;24:78–80.CrossRef
7.
go back to reference Ali BH, Ziada A, Al Husseni I, Beegam S, Nemmar A. Motor and behavioral changes in rats with adenine-induced chronic renal failure: influence of acacia gum treatment. Exp Biol Med. 2011;236:107–12 (Maywood).CrossRef Ali BH, Ziada A, Al Husseni I, Beegam S, Nemmar A. Motor and behavioral changes in rats with adenine-induced chronic renal failure: influence of acacia gum treatment. Exp Biol Med. 2011;236:107–12 (Maywood).CrossRef
8.
go back to reference Tsuruya K. Brain atrophy and cognitive impairment in patients with chronic kidney disease. Nihon Rinsho. 2014;72:708–14 (in Japanese).PubMed Tsuruya K. Brain atrophy and cognitive impairment in patients with chronic kidney disease. Nihon Rinsho. 2014;72:708–14 (in Japanese).PubMed
9.
go back to reference Jing W, Jabbari B, Vaziri ND. Uremia induces upregulation of cerebral tissue oxidative/inflammatory cascade, down-regulation of Nrf2 pathway and disruption of blood brain barrier. Am J Transl Res. 2018;10:2137–47.PubMedPubMedCentral Jing W, Jabbari B, Vaziri ND. Uremia induces upregulation of cerebral tissue oxidative/inflammatory cascade, down-regulation of Nrf2 pathway and disruption of blood brain barrier. Am J Transl Res. 2018;10:2137–47.PubMedPubMedCentral
10.
go back to reference Adesso S, Paterniti I, Cuzzocrea S, Fujioka M, Autore G, Magnus T, Pinto A, Marzocco S. AST-120 reduces neuroinflammation induced by indoxyl sulfate in glial cells. J Clin Med. 2018;7:365.CrossRef Adesso S, Paterniti I, Cuzzocrea S, Fujioka M, Autore G, Magnus T, Pinto A, Marzocco S. AST-120 reduces neuroinflammation induced by indoxyl sulfate in glial cells. J Clin Med. 2018;7:365.CrossRef
11.
go back to reference Malouf R, Brust JC. Hypoglycemia: causes, neurological manifestations, and outcome. Ann Neurol. 1985;17:421–30.CrossRef Malouf R, Brust JC. Hypoglycemia: causes, neurological manifestations, and outcome. Ann Neurol. 1985;17:421–30.CrossRef
12.
go back to reference Votey SR, Peters AL, Hoffman JR. Disorders of water metabolism: hyponatremia and hypernatremia. Emerg Med Clin North Am. 1989;7:749–69.PubMed Votey SR, Peters AL, Hoffman JR. Disorders of water metabolism: hyponatremia and hypernatremia. Emerg Med Clin North Am. 1989;7:749–69.PubMed
13.
go back to reference Gorban-Brennan N, Kliger AS, Finkelstein FO. CAPD therapy for patients over 80 years of age. Perit Dial Int. 1993;13:140–1.PubMed Gorban-Brennan N, Kliger AS, Finkelstein FO. CAPD therapy for patients over 80 years of age. Perit Dial Int. 1993;13:140–1.PubMed
14.
go back to reference Taskapan H, Tam P, Leblanc D, Ting RH, Nagai GR, Chow SS, Fung J, Ng PS, Sikaneta T, Roscoe J, Oreopoulos DG. Peritoneal dialysis in the nursing home. Int Urol Nephrol. 2010;42:545–51.CrossRef Taskapan H, Tam P, Leblanc D, Ting RH, Nagai GR, Chow SS, Fung J, Ng PS, Sikaneta T, Roscoe J, Oreopoulos DG. Peritoneal dialysis in the nursing home. Int Urol Nephrol. 2010;42:545–51.CrossRef
15.
go back to reference Chow KM, Wang AYM, Hui ACF, Wong TYH, Szeto CC, Li PKT. Nonconvulsive status epilepticus in peritoneal dialysis patients. Am J Kidney Dis. 2001;38:400–5.CrossRef Chow KM, Wang AYM, Hui ACF, Wong TYH, Szeto CC, Li PKT. Nonconvulsive status epilepticus in peritoneal dialysis patients. Am J Kidney Dis. 2001;38:400–5.CrossRef
16.
go back to reference Hung SC, Hung SH, Tarng DC, Yang YC, Chen TW, Huang TP. Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 2001;38:941–7.CrossRef Hung SC, Hung SH, Tarng DC, Yang YC, Chen TW, Huang TP. Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 2001;38:941–7.CrossRef
17.
go back to reference Chow KM, Szeto CC, Hui AC, Wong TY, Li PK. Retrospective review of neurotoxicity induced by cefepime and ceftazidime. Pharmacotherapy. 2003;23:369–73.CrossRef Chow KM, Szeto CC, Hui AC, Wong TY, Li PK. Retrospective review of neurotoxicity induced by cefepime and ceftazidime. Pharmacotherapy. 2003;23:369–73.CrossRef
18.
go back to reference Tong MK, Siu YP, Yung CY, Kwan TH. Piperacillin/tazobactam-induced acute delirium in a peritoneal dialysis patient. Nephrol Dial Transplant. 2004;19:1341.CrossRef Tong MK, Siu YP, Yung CY, Kwan TH. Piperacillin/tazobactam-induced acute delirium in a peritoneal dialysis patient. Nephrol Dial Transplant. 2004;19:1341.CrossRef
19.
go back to reference Lin CS, Cheng CJ, Chou CH, Lin SH. Piperacillin/tazobactam-induced seizure rapidly reversed by high flux hemodialysis in a patient on peritoneal dialysis. Am J Med Sci. 2007;333:181–4.CrossRef Lin CS, Cheng CJ, Chou CH, Lin SH. Piperacillin/tazobactam-induced seizure rapidly reversed by high flux hemodialysis in a patient on peritoneal dialysis. Am J Med Sci. 2007;333:181–4.CrossRef
20.
go back to reference Ardalan MR, Pourafkari L, Tubbs RS, Shoja MM. Hypophosphatemic encephalopathy in a CAPD patient. Am J Med Sci. 2008;335:492–4.CrossRef Ardalan MR, Pourafkari L, Tubbs RS, Shoja MM. Hypophosphatemic encephalopathy in a CAPD patient. Am J Med Sci. 2008;335:492–4.CrossRef
21.
go back to reference Kitamura M, Furusu A, Hirose M, Nishino T, Obata Y, Uramatsu T, Kohno S. A case of reversible posterior leukoencephalopathy syndrome in a patient on peritoneal dialysis. Clin Exp Nephrol. 2010;14:633–6.CrossRef Kitamura M, Furusu A, Hirose M, Nishino T, Obata Y, Uramatsu T, Kohno S. A case of reversible posterior leukoencephalopathy syndrome in a patient on peritoneal dialysis. Clin Exp Nephrol. 2010;14:633–6.CrossRef
22.
go back to reference Lin CJ, Chen SP, Wang SJ, Fuh JL. Cefepime-related encephalopathy in peritoneal dialysis patients. J Chin Med Assoc. 2011;74:87–90.CrossRef Lin CJ, Chen SP, Wang SJ, Fuh JL. Cefepime-related encephalopathy in peritoneal dialysis patients. J Chin Med Assoc. 2011;74:87–90.CrossRef
23.
go back to reference Ogawa A, Sugiyama H, Nakayama K, Morinaga H, Akagi S, Makino H. Reversible posterior leukoencephalopathy syndrome in a young adult patient receiving peritoneal dialysis. Perit Dial Int. 2012;32:587–9.CrossRef Ogawa A, Sugiyama H, Nakayama K, Morinaga H, Akagi S, Makino H. Reversible posterior leukoencephalopathy syndrome in a young adult patient receiving peritoneal dialysis. Perit Dial Int. 2012;32:587–9.CrossRef
24.
go back to reference Lee J, Shin HS, Jung YS, Rim H. Two cases of baclofen-induced encephalopathy in hemodialysis and peritoneal dialysis patients. Ren Fail. 2013;35:860–2.CrossRef Lee J, Shin HS, Jung YS, Rim H. Two cases of baclofen-induced encephalopathy in hemodialysis and peritoneal dialysis patients. Ren Fail. 2013;35:860–2.CrossRef
25.
go back to reference Safadi S, Mao M, Dillon JJ. Ceftriaxone-induced acute encephalopathy in a peritoneal dialysis patient. Case Rep Nephrol. 2014;2014:108185.PubMedPubMedCentral Safadi S, Mao M, Dillon JJ. Ceftriaxone-induced acute encephalopathy in a peritoneal dialysis patient. Case Rep Nephrol. 2014;2014:108185.PubMedPubMedCentral
26.
go back to reference Graham BR, Pylypchuk GB. Posterior reversible encephalopathy syndrome in an adult patient undergoing peritoneal dialysis: a case report and literature review. BMC Nephrol. 2014;15:10.CrossRef Graham BR, Pylypchuk GB. Posterior reversible encephalopathy syndrome in an adult patient undergoing peritoneal dialysis: a case report and literature review. BMC Nephrol. 2014;15:10.CrossRef
27.
go back to reference Chaitanya V, Sangeetha B, Reddy MH, Venkata Kumar AC, Ram R, Sivakumar V. Isoniazid cerebellitis in a peritoneal dialysis patient. Nephrology. 2016;21:442 (Carlton).CrossRef Chaitanya V, Sangeetha B, Reddy MH, Venkata Kumar AC, Ram R, Sivakumar V. Isoniazid cerebellitis in a peritoneal dialysis patient. Nephrology. 2016;21:442 (Carlton).CrossRef
28.
go back to reference Kim CS, Bae EH, Ma SK, Kim SW. The case| seizure, ophthalmoplegia, and amnesia in a peritoneal dialysis patient. Kidney Int. 2016;90:1389–90.CrossRef Kim CS, Bae EH, Ma SK, Kim SW. The case| seizure, ophthalmoplegia, and amnesia in a peritoneal dialysis patient. Kidney Int. 2016;90:1389–90.CrossRef
29.
go back to reference Nicotera R, Leonardi G, Castagna A, Cernaro V, Coppolino G. Wernicke–Korsakoff syndrome in end-stage renal disease: a case report. Ther Apher Dial. 2018;22:676–9.CrossRef Nicotera R, Leonardi G, Castagna A, Cernaro V, Coppolino G. Wernicke–Korsakoff syndrome in end-stage renal disease: a case report. Ther Apher Dial. 2018;22:676–9.CrossRef
Metadata
Title
Uremic encephalopathy in patients undergoing assisted peritoneal dialysis: a case series and literature review
Authors
Akane Yanai
Kiyotaka Uchiyama
Yoshitaka Ishibashi
Publication date
01-11-2019
Publisher
Springer Singapore
Published in
CEN Case Reports / Issue 4/2019
Electronic ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-019-00406-3

Other articles of this Issue 4/2019

CEN Case Reports 4/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.